
Gabriel Ghiaur, MD, PhD
Hematologic Malignancy
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Gabriel Ghiaur
Primary Academic Title
Associate Professor of Oncology
Background
Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in cell extrinsic drug resistance and persistence of minimal residual disease. He has distinguished himself as an outstanding laboratory-based investigator and a superior clinician. His research has translational potential in stem cell therapeutics, as well as acute leukemia and multiple myeloma.
Centers and Institutes
Clinical Trial Keywords
Leukemia, Bone Marrow Transplant, Hematologic Malignancies, Natural Killer Cells
Research Interests
Bone Marrow Microenvironment, Bone Marrow Transplant, Hematopoietic Stem Cell Biology and Leukemia Stem Cells, Leukemia, Natural Killer Cells
Selected Publications
Ghiaur G, Levis M. Mechanisms of Resistance to FLT3 Inhibitors and the Role of the Bone Marrow Microenvironment. Hematol Oncol Clin North Am. 2017 Aug;31(4):681-692. doi: 10.1016/j.hoc.2017.04.005. Epub 2017 May 18. Review. PubMed PMID: 28673395; PubMed Central PMCID: PMC5512588.
Ghiaur G, Yegnasubramanian S, Perkins B, Gucwa J, Gerber J, and Jones RJ. Regulation of Hematopoietic Stem Cell Self-Renewal by the Microenvironment’s Control of Retinoic Acid Signaling. PNAS, 2013, Oct1; 110(40):16121-6. Epub 2013 Sep 16. PMID: 24043786. PMCID: PMC3791732
Alonso S, Hernandez D, Chang YT, Gocke CD, McCray M, Varadhan R, Matsui WH, Jones RJ, Ghiaur G. Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance. J Clin Invest. 2016 Dec 1;126(12):4460-4468. doi: 10.1172/JCI88152 PMID: 27775549
Hernandez D, Palau L, Norsworthy K, Anders NM, Alonso S, Su M, Petkovich M, Chandraratna R, Rudek MA, Smith BD, Jones RJ, Ghiaur G. Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids. Leukemia. 2020 Mar 9;. doi: 10.1038/s41375-020-0790-4. [Epub ahead of print] PubMed PMID: 32152463.
Su M, Chang YT, Hernandez D, Jones RJ, Ghiaur G. Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment. J Cell Mol Med. 2019 Jun;23(6):4111-4117. doi: 10.1111/jcmm.14298. Epub 2019 Mar 28. PubMed PMID: 30920135; PubMed Central PMCID: PMC6533513
Honors
- Blood Mentor, ASH-a-Palooza, American Society of Hematology Annual Meeting, 1/1/19
- Visiting Professor in Hematopoiesis, Cluj School of Medicine, 1/1/18
- American Society of Clinical Investigator (ASCI) Young Physician-Scientist Award, 1/1/17
- Passano Physician Scientist Award, 1/1/14
- Fellow, American Society of Hematology, 1/1/12
- Fellow, Maryland Stem Cell Research, 1/1/12
Memberships
- American Association of Cancer Research
- American Society of Hematology
- Romanian Society of Hematology
- Romanian Society of Bone Marrow Transplantation, Honorary Member
Professional Activities
- Education Committee, Sidney Kimmel Comprehensive Cancer Center, Associate Chair
- Normal and Oncologic Tissue Collection Hub (NOTCH) biorepository, Director
- Visiting Professor Series and Translational Research Conference, Director
Locations
- Sidney Kimmel Comprehensive Cancer Center
- 401 North Broadway Street, Weinberg BLDG, Baltimore, MD 21287
- phone: 410-955-8964
- fax: 410-367-2194
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Hematology, 2013The Christ Hospital
Residency, Internal Medicine, 2009University of Cincinnati
Graduate School, Molecular Biology, PhD, 2008Carol Davila University of Medicine
Medical Education, MD, 2001Board Certifications
Hematology
American Board of Internal Medicine, 2011Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)